Related Experiment Video
Updated: Nov 9, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.3K
Mediation analysis for mixture Cox proportional hazards cure models
1Department of Statistics, 26451Chinese University of Hong Kong, Hong Kong.
Statistical Methods in Medical Research
|April 9, 2021
Summary
This study introduces a new mediation analysis method for cure models, addressing the challenge of subjects who never experience an event. The approach effectively assesses causal pathways in survival data, including in Alzheimer's disease research.
Area of Science:
- Biostatistics
- Survival Analysis
- Causal Inference
Background:
- Mediation analysis decomposes total effects into causal pathways.
- Existing survival models struggle with a significant 'cure fraction' (subjects never experiencing the event).
Purpose of the Study:
- To develop mediation analysis for cure fraction problems using mixture cure models.
- To assess path-specific effects on survival outcomes like restricted mean survival time.
Main Methods:
- Utilizes a three-stage mediation framework with a partially latent group indicator.
- Employs a Bayesian approach with P-splines for the baseline hazard function.
- Applies the mediation formula approach to estimate effects.
Main Results:
- The proposed method demonstrates satisfactory performance in simulation studies.
- Successfully applied to investigate APOE- allele effects on Alzheimer's disease progression using real-world data.
Conclusions:
- The novel method effectively handles mediation analysis in the presence of cure fractions.
- Provides a robust framework for understanding causal mechanisms in survival data, applicable to complex diseases like Alzheimer's.
Keywords:
Bayesian sensitivity analysiscured subgrouplatent variablemediation analysispath-specific effectsMore Related Videos
Related Concept Videos
The Mantel-Cox Log-Rank Test
740
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
740
Comparing the Survival Analysis of Two or More Groups
384
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
384
Assumptions of Survival Analysis
234
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
234
Hazard Rate
249
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
249
Cancer Survival Analysis
504
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
504
Kaplan-Meier Approach
352
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
352

